Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries

47Citations
Citations of this article
145Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

Background: To the authors' knowledge, the impact of the coronavirus disease 2019 (COVID-19) pandemic on cytopathology practices worldwide has not been investigated formally. In the current study, data from 41 respondents from 23 countries were reported. Methods: Data regarding the activity of each cytopathology laboratory during 4 weeks of COVID-19 lockdown were collected and compared with those obtained during the corresponding period in 2019. The overall number and percentage of exfoliative and fine-needle aspiration cytology samples from each anatomic site were recorded. Differences in the malignancy and suspicious rates between the 2 periods were analyzed using a meta-analytical approach. Results: Overall, the sample volume was lower compared with 2019 (104,319 samples vs 190,225 samples), with an average volume reduction of 45.3% (range, 0.1%-98.0%). The percentage of samples from the cervicovaginal tract, thyroid, and anorectal region was significantly reduced (P

Cite

CITATION STYLE

APA

Vigliar, E., Cepurnaite, R., Alcaraz-Mateos, E., Ali, S. Z., Baloch, Z. W., Bellevicine, C., … Troncone, G. (2020). Global impact of the COVID-19 pandemic on cytopathology practice: Results from an international survey of laboratories in 23 countries. Cancer Cytopathology, 128(12), 885–894. https://doi.org/10.1002/cncy.22373

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free